1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Fubei Biotechnology (Suzhou)

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2017

Location

Suzhou Jiangsu China

Primary Industry

Biotechnology

About

Established in 2017 and based in Suzhou, China, Fubei Biotechnology (Suzhou) operates as a neurological drug developer dedicated to providing novel medicines for neurodegenerative diseases and neurological injuries. The co-founder and CEO, Xiaoming Guan, has 27 years of R&D and leadership experience in the pharmaceutical industry. Up to now, there are 9 innovative projects in the R&D pipeline, including small-molecule chemical drugs and large-molecule biologics. In addition, potential drug candidates FB1003 and FB1008 for the treatment of chronic pain and Alzheimer's disease are in the preclinical stage.
Current Investors
Gaorong Ventures, China Growth Capital, Foothill Ventures

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.4btechnologies.com
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.